Download presentation
Presentation is loading. Please wait.
Published byAlexia Armstrong Modified over 6 years ago
1
Patient-Centered Prescription Labels: Academic Perspective
Clark Kebodeaux, Pharm.D., BCACP
2
Background St. Louis College of Pharmacy
Center for Patient Education and Health Literacy University of Kentucky College of Pharmacy USP-NF General Chapter <17> Prescription Container Labeling Community/Ambulatory Care Pharmacy Experience
3
Goals Evaluate the quality of prescription container labels and measure the adherence to USP Chapter 17 Use the output to identify opportunities for change through state-level regulation and within pharmacies/health-systems Increase awareness of the importance of labeling within the pharmacy community
4
Patients Focus Groups Major Themes
Thematic analysis of patients in the state of Missouri Confirm patient-perceived prescription content and formatting expectations for prescription container labeling consistency with USP Chapter 17 Major Themes Importance of drug name, dose, and directions Lack of side effects on the label Improved organization and larger font size Using the color red Lack of familiarity with auxiliary labels The importance of pharmacy information Kebodeaux, Clark D., et al. "Patient-perceived content and formatting expectations for prescription container labeling." Journal of the American Pharmacists Association 56.3 (2016):
5
Stakeholders Community Pharmacists Previous Research State of Missouri
Chain (>4 locations) Independent Grocery Mass Merchandizer Academicians Health literacy Pharmacy Previous Research The variability and quality of medication container labels. Archives of internal medicine (2007) State of Missouri One state used for consistency of regulations Missouri has not adopted patient- centered prescription regulations Shrank, W. H., Agnew-Blais, J., Choudhry, N. K., Wolf, M. S., Kesselheim, A. S., Avorn, J., & Shekelle, P. (2007). The variability and quality of medication container labels. Archives of internal medicine, 167(16),
6
Prescription Evaluation
USP Chapter 17 Parameters Present among 80 Label Sample Set Patient name at top Spell out full brand name Spell out full generic name List strength No jargon/medication abbreviation Separate dose and timing Avoid use of hours in the SIG (instructions) Use numbers rather than alphabet characters Include purpose for use Team identified 22 measureable items from the USP Chapter 17 18 were used in final analysis
7
Prescription Evaluation
USP Chapter 17 Parameters Present among 80 Label Sample Set High contrast (black ink on white label) Sentence case (including initial capital and period) Font size > 11 for drug name, patient name, SIG Font size no less than 10 for other content No vertical text No more than 2 colors of highlights Font readability (Arial/Times New Roman) Adequate white space No “bad bolding” (other than patient/refill) Team identified 22 measureable items from the USP Chapter 17 18 were used in final analysis
8
Prescriptions
9
Results High Performing Measurements
Kebodeaux C, Peters GL, Kindermann H, Hurd P and Berry T. Prescription Labels: Adherence to USP Chapter 17 Standards. J Am Pharm Assoc. 2017;Presentend at the APhA Annual Meeting; San Francisco, CA.
10
Results Low Performing Measurements
Kebodeaux C, Peters GL, Kindermann H, Hurd P and Berry T. Prescription Labels: Adherence to USP Chapter 17 Standards. J Am Pharm Assoc. 2017;Presentend at the APhA Annual Meeting; San Francisco, CA.
11
Results Measurements by Pharmacy Type
Kebodeaux C, Peters GL, Kindermann H, Hurd P and Berry T. Prescription Labels: Adherence to USP Chapter 17 Standards. J Am Pharm Assoc. 2017;Presentend at the APhA Annual Meeting; San Francisco, CA.
12
Prescriptions 1 2 3 4
13
Results Measurements by Prescription Differences
Kebodeaux C, Peters GL, Kindermann H, Hurd P and Berry T. Prescription Labels: Adherence to USP Chapter 17 Standards. J Am Pharm Assoc. 2017;Presentend at the APhA Annual Meeting; San Francisco, CA.
14
Outcomes System Level Changes Expected Outcomes Unexpected Outcomes
Pharmacy Systems/Technology Pharmacists Prescribers Regulators Expected Outcomes Unexpected Outcomes Successes/Challenges/Recommendations
15
Questions?
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.